EUVIMEDEUVIMED entdecken
Crossref

A novel formula to improve the accuracy and prognostic ability of determining the survival time after recurrent breast cancer

Reiki Nishimura, Yasuaki Sagara, Reiko Mitsueda, Tetsuhiko Taira, Toshiko Miyaki, Shuichi Kanemitsu, Megumi Teraoka, Junko Kawano, Naomi Gondo, Yoshitaka Fujiki, Ryutaro Higashi, Akiko Semba und 4 weitere

Breast Cancer · 2025

DOI: 10.1007/s12282-025-01677-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer, 2025. Verfasst von Reiki Nishimura und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgical Oncology, Sagara Hospital, Social Medical Corporation Hakuaikai, Kagoshima City, Kagoshima, 892-0833, Japan…. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoplasm Recurrence, Local. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Recurrent breast cancer (BC) has poor prognosis. To ascertain the survival time after recurrence (STR) is necessary for improving QOL and for selecting appropriate treatment. An investigation was conducted to determine whether certain biomarkers would improve prognosis and whether the disease-free interval (DFI) and biomarkers can predict STR. METHODS: Cases (n = 1,254) with recurrent BC from January 2000 to December 2023 were enrolled in this study. The cases were divided into the 2000-2005 group (n = 182), 2006-2011 group (n = 331), 2012-2017 group (n = 369), and 2018-2023 group (n = 366). A simple linear regression model was used to identify the relationship between STR and DFI. RESULTS: Survival rates after recurrence significantly increased in cases after 2012. No improvement was observed in cases with a HER2-0 status and a Ki-67 index value 30%, followed by HER2-low, tumor size ≤ 2 cm and ER 30% and a HER2-low status. Further studies need to be conducted in clinical settings to verify the accuracy of the predictive formula developed for STR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsNeoplasm Recurrence, LocalHumansFemaleMiddle AgedPrognosisBiomarkers, TumorErb-b2 Receptor Tyrosine KinasesAdultAgedKi-67 AntigenRetrospective StudiesReceptors, EstrogenSurvival RateDisease-Free Survival

Stichwörter der Autor:innen

Breast cancerDisease-free intervalKi-67RecurrenceSurvival after recurrence

Substanzen

Biomarkers, TumorErb-b2 Receptor Tyrosine KinasesKi-67 AntigenReceptors, EstrogenERBB2 protein, human

Autor:innen und Institutionen

  • Department of Breast and Thyroid Surgical Oncology, Sagara Hospital, Social Medical Corporation Hakuaikai, Kagoshima City, Kagoshima, 892-0833, Japan. nishirei@ymail.ne.jp.
  • Department of Breast and Thyroid Surgical Oncology, Sagara Hospital, Social Medical Corporation Hakuaikai, Kagoshima City, Kagoshima, 892-0833, Japan.
  • Clinical Oncology, Sagara Hospital, Social Medical Corporation Hakuaikai, Kagoshima City, Japan.
  • Radiology, Sagara Hospital, Social Medical Corporation Hakuaikai, Kagoshima City, Japan.
  • Pathology, Sagara Hospital, Social Medical Corporation Hakuaikai, Kagoshima City, Japan.

Zitieren

APA

Nishimura, R., Sagara, Y., Mitsueda, R., Taira, T., Miyaki, T., Kanemitsu, S., Teraoka, M., Kawano, J., Gondo, N., Fujiki, Y., Higashi, R., Semba, A., Ohi, Y., Rai, Y., Sagara, Y., & Ohno, S. (2025). A novel formula to improve the accuracy and prognostic ability of determining the survival time after recurrent breast cancer. Breast Cancer. https://doi.org/10.1007/s12282-025-01677-8

Vancouver

Nishimura R, Sagara Y, Mitsueda R, Taira T, Miyaki T, Kanemitsu S, et al. A novel formula to improve the accuracy and prognostic ability of determining the survival time after recurrent breast cancer. Breast Cancer. 2025. doi:10.1007/s12282-025-01677-8

BibTeX
@article{Nishimura2025,
  author = {Nishimura, Reiki and Sagara, Yasuaki and Mitsueda, Reiko and Taira, Tetsuhiko and Miyaki, Toshiko and Kanemitsu, Shuichi and Teraoka, Megumi and Kawano, Junko and Gondo, Naomi and Fujiki, Yoshitaka and Higashi, Ryutaro and Semba, Akiko and Ohi, Yasuyo and Rai, Yoshiaki and Sagara, Yoshiaki and Ohno, Shinji},
  title = {A novel formula to improve the accuracy and prognostic ability of determining the survival time after recurrent breast cancer},
  journal = {Breast Cancer},
  year = {2025},
  doi = {10.1007/s12282-025-01677-8}
}
Kostenlos starten →